BullFrog AI (BFRG) stock jumped 106% after announcing a drug discovery deal with a top-5 pharma firm targeting major ...

BullFrog AI (BFRG) stock surged 101% after securing a commercial partnership with a top 5 pharma company for depression drug target identification.

Multiple SIRS presentations underscore the potential of LB-102 to address positive, negative, and cognitive symptom domains ...

Reported positive results from potentially registrational Phase 2 trial ofLB-102 in schizophrenia Advanced LB-102 into late-stage development in multiple indications with initiation ofa pivotal Phase ...

LB-102 has potential to be the first benzamide approved for schizophrenia in the U.S. NOVA-2 trial to enroll approximately ...

Cybin Inc (NASDAQ:HELP) is among the best psychedelic stocks to buy in 2026. Toronto, Canada-based Cybin Inc. is also known ...

Neuronetics, Inc. 2026 turnaround? New CEO Dan Reuvers and the Greenbrook deal drove revenue growth—see key valuation and ...

Background Alcohol use disorder and treatment-resistant depression (TRD) often co-occur, presenting a major clinical challenge with limited effective treatments. However, ketamine produces rapid ...

Understanding what the US spends to treat mental health and substance use disorders (SUD) is important for understanding spending patterns and informing health policy. In this study, we determined ...

This systematic review included 54 studies, comprising 30 brain studies, 20 blood studies, and 4 analysing both tissues. Across datasets, 744 differentially expressed genes were altered in the same ...

If you have major depressive disorder (MDD), chances are you might feel drained even after a nap or a good night’s sleep. The two main characteristics of MDD are a depressed mood and decreased ...